Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regeneron Pharmaceuticals Revenue 2010-2025 | REGN

Regeneron Pharmaceuticals annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Regeneron Pharmaceuticals revenue for the quarter ending March 31, 2025 was $3.029B, a 3.7% decline year-over-year.
  • Regeneron Pharmaceuticals revenue for the twelve months ending March 31, 2025 was $14.086B, a 7.52% increase year-over-year.
  • Regeneron Pharmaceuticals annual revenue for 2024 was $14.202B, a 8.27% increase from 2023.
  • Regeneron Pharmaceuticals annual revenue for 2023 was $13.117B, a 7.76% increase from 2022.
  • Regeneron Pharmaceuticals annual revenue for 2022 was $12.173B, a 24.26% decline from 2021.
  
Regeneron Pharmaceuticals Annual Revenue
(Millions of US $)
2024 $14,202
2023 $13,117
2022 $12,173
2021 $16,072
2020 $8,497
2019 $6,558
2018 $5,146
2017 $5,872
2016 $4,860
2015 $4,104
2014 $2,820
2013 $2,105
2012 $1,378
2011 $446
2010 $459
2009 $379
Regeneron Pharmaceuticals Quarterly Revenue
(Millions of US $)
2025-03-31 $3,029
2024-12-31 $3,789
2024-09-30 $3,721
2024-06-30 $3,547
2024-03-31 $3,145
2023-12-31 $3,434
2023-09-30 $3,363
2023-06-30 $3,158
2023-03-31 $3,162
2022-12-31 $3,414
2022-09-30 $2,936
2022-06-30 $2,857
2022-03-31 $2,965
2021-12-31 $4,952
2021-09-30 $3,453
2021-06-30 $5,139
2021-03-31 $2,529
2020-12-31 $2,423
2020-09-30 $2,294
2020-06-30 $1,952
2020-03-31 $1,828
2019-12-31 $1,864
2019-09-30 $1,744
2019-06-30 $1,578
2019-03-31 $1,373
2018-12-31 $363
2018-09-30 $1,664
2018-06-30 $1,608
2018-03-31 $1,512
2017-12-31 $1,582
2017-09-30 $1,501
2017-06-30 $1,470
2017-03-31 $1,319
2016-12-31 $1,227
2016-09-30 $1,220
2016-06-30 $1,213
2016-03-31 $1,201
2015-12-31 $1,098
2015-09-30 $1,137
2015-06-30 $999
2015-03-31 $870
2014-12-31 $802
2014-09-30 $726
2014-06-30 $666
2014-03-31 $626
2013-12-31 $610
2013-09-30 $597
2013-06-30 $458
2013-03-31 $440
2012-12-31 $415
2012-09-30 $428
2012-06-30 $304
2012-03-31 $232
2011-12-31 $123
2011-09-30 $103
2011-06-30 $108
2011-03-31 $112
2010-12-31 $134
2010-09-30 $106
2010-06-30 $116
2010-03-31 $104
2009-12-31 $97
2009-09-30 $117
2009-06-30 $90
2009-03-31 $75
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $56.250B $14.202B
Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also developed an antibody cocktail for COVID-19, REGEN-COV. REGEN-COV is a cocktail of two monoclonal antibodies and was designed specifically to block the infectivity of SARS-CoV-2, the virus that causes COVID-19. Regeneron has a collaboration agreement with Roche for the same. While Regeneron has co-developed Eylea with Bayer's HealthCare unit, Praluent was co-developed with Sanofi. Regeneron collaborated with Bayer for the joint development and commercialization of co-formulated combinations of Eylea, rinucumab and nesvacumab for the treatment of ocular diseases or disorders outside the United States.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $216.627B 16.17
Amgen (AMGN) United States $149.014B 13.35
Gilead Sciences (GILD) United States $137.666B 14.30
Vertex Pharmaceuticals (VRTX) United States $113.325B 0.00
Bristol Myers Squibb (BMY) United States $94.326B 6.31
GSK (GSK) United Kingdom $78.987B 9.46
CSL (CSLLY) Australia $74.627B 0.00
Alnylam Pharmaceuticals (ALNY) United States $42.093B 0.00
Argenex SE (ARGX) Netherlands $34.202B 93.36
BioNTech SE (BNTX) Germany $25.655B 0.00
Royalty Pharma (RPRX) United States $20.168B 8.52
Insmed (INSM) United States $18.875B 0.00
Biogen (BIIB) United States $18.474B 7.97
Illumina (ILMN) United States $15.005B 28.47
Genmab (GNMSF) Denmark $13.948B 14.26
Incyte (INCY) United States $13.234B 100.54
Genmab (GMAB) Denmark $13.145B 14.75
Exelixis (EXEL) United States $11.909B 20.22
QIAGEN (QGEN) Netherlands $10.619B 20.66
BioMarin Pharmaceutical (BMRN) United States $10.580B 17.19
Ascendis Pharma (ASND) Denmark $10.528B 0.00
Moderna (MRNA) United States $10.504B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Exact Sciences (EXAS) United States $10.120B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $8.604B 0.00
Blueprint Medicines (BPMC) United States $8.274B 0.00
Bio-Techne Corp (TECH) United States $8.127B 30.32
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.987B 0.00
Roivant Sciences (ROIV) United Kingdom $7.743B 0.00
Repligen (RGEN) United States $6.942B 77.71
Revolution Medicines (RVMD) United States $6.875B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Jazz Pharmaceuticals (JAZZ) Ireland $6.469B 6.35
Halozyme Therapeutics (HALO) United States $6.433B 12.31
Legend Biotech (LEGN) United States $6.364B 0.00
Guardant Health (GH) United States $6.301B 0.00
TG Therapeutics (TGTX) United States $5.829B 153.00
Nuvalent (NUVL) United States $5.722B 0.00
Telix Pharmaceuticals (TLX) Australia $5.412B 0.00
Axsome Therapeutics (AXSM) United States $5.089B 0.00
Alkermes (ALKS) Ireland $4.751B 12.75
Anbio Biotechnology (NNNN) Germany $4.491B 0.00
Akero Therapeutics (AKRO) United States $4.479B 0.00
ADMA Biologics Inc (ADMA) United States $4.335B 32.43
Vaxcyte (PCVX) United States $4.203B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.101B 0.00
Krystal Biotech (KRYS) United States $4.013B 30.93
Rhythm Pharmaceuticals (RYTM) United States $3.991B 0.00
Zealand Pharma (ZLDPF) Denmark $3.985B 0.00
Cytokinetics (CYTK) United States $3.960B 0.00
PTC Therapeutics (PTCT) United States $3.950B 6.87
Zai Lab (ZLAB) China $3.833B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.702B 32.53
Merus (MRUS) Netherlands $3.668B 0.00
Arcellx (ACLX) United States $3.601B 0.00
SpringWorks Therapeutics (SWTX) United States $3.540B 0.00
Avidity Biosciences (RNA) United States $3.499B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.453B 0.00
Protagonist Therapeutics (PTGX) United States $3.452B 74.25
Ascentage Pharma Group - (AAPG) China $3.450B 0.00
Scholar Rock Holding (SRRK) United States $3.400B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.042B 0.00
Metsera (MTSR) United States $3.004B 0.00
Viking Therapeutics (VKTX) United States $2.978B 0.00
Kymera Therapeutics (KYMR) United States $2.873B 0.00
Alvotech (ALVO) Luxembourg $2.756B 15.76
Immunovant (IMVT) United States $2.752B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.632B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.531B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.486B 0.00
ImmunityBio (IBRX) United States $2.383B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.221B 0.00
Ligand Pharmaceuticals (LGND) United States $2.202B 0.00
Apellis Pharmaceuticals (APLS) United States $2.191B 0.00
Twist Bioscience (TWST) United States $2.153B 0.00
Vericel (VCEL) United States $2.101B 1391.00
Bavarian Nordic (BVNRY) Denmark $2.088B 11.03
Denali Therapeutics (DNLI) United States $2.048B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.046B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.045B 0.00
NovoCure (NVCR) Jersey $2.007B 0.00
Apogee Therapeutics (APGE) United States $1.998B 0.00
CG Oncology (CGON) United States $1.978B 0.00
Agios Pharmaceuticals (AGIO) United States $1.938B 0.00
Disc Medicine (IRON) United States $1.888B 0.00
Belite Bio (BLTE) United States $1.880B 0.00
IDEAYA Biosciences (IDYA) United States $1.872B 0.00
Certara (CERT) United States $1.846B 34.48
Harmony Biosciences Holdings (HRMY) United States $1.836B 12.21
Amicus Therapeutics (FOLD) United States $1.826B 197.67
Adaptive Biotechnologies (ADPT) United States $1.791B 0.00
GRAIL (GRAL) United States $1.741B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.695B 0.00
Beam Therapeutics (BEAM) United States $1.689B 0.00
Sarepta Therapeutics (SRPT) United States $1.682B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.638B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.563B 0.00
Vera Therapeutics (VERA) United States $1.444B 0.00
89BIO (ETNB) United States $1.439B 0.00
Biohaven (BHVN) United States $1.439B 0.00
ANI Pharmaceuticals (ANIP) United States $1.419B 14.62
Mesoblast (MESO) Australia $1.395B 0.00
Edgewise Therapeutics (EWTX) United States $1.385B 0.00
Janux Therapeutics (JANX) United States $1.370B 0.00
Celldex Therapeutics (CLDX) United States $1.347B 0.00
Travere Therapeutics (TVTX) United States $1.312B 0.00
Structure Therapeutics (GPCR) United States $1.209B 0.00
CureVac (CVAC) Germany $1.207B 5.85
Dynavax Technologies (DVAX) United States $1.190B 70.79
Viridian Therapeutics (VRDN) United States $1.169B 0.00
BGM Group (BGM) China $1.164B 0.00
MannKind (MNKD) United States $1.143B 23.50
Niagen Bioscience (NAGE) United States $1.120B 158.00
Liquidia Technologies (LQDA) United States $1.120B 0.00
Pacira BioSciences (PCRX) United States $1.087B 10.34
AbCellera Biologics (ABCL) Canada $1.077B 0.00
WAVE Life Sciences (WVE) Singapore $1.038B 0.00
Novavax (NVAX) United States $1.032B 2.40
Intellia Therapeutics (NTLA) United States $0.990B 0.00
Geron (GERN) United States $0.949B 0.00
NeoGenomics (NEO) United States $0.924B 0.00
Spyre Therapeutics (SYRE) United States $0.917B 0.00
Mineralys Therapeutics (MLYS) United States $0.894B 0.00
Pharvaris (PHVS) Netherlands $0.889B 0.00
Nurix Therapeutics (NRIX) United States $0.887B 0.00
Oric Pharmaceuticals (ORIC) United States $0.879B 0.00
MiMedx (MDXG) United States $0.877B 21.21
Praxis Precision Medicines (PRAX) United States $0.876B 0.00
Zymeworks (ZYME) United States $0.868B 0.00
LENZ Therapeutics (LENZ) United States $0.849B 0.00
CorMedix Inc (CRMD) United States $0.848B 56.82
Oculis Holding AG (OCS) Switzerland $0.845B 0.00
Arcus Biosciences (RCUS) United States $0.842B 0.00
Anavex Life Sciences (AVXL) United States $0.809B 0.00
Cogent Biosciences (COGT) United States $0.808B 0.00
ArriVent BioPharma (AVBP) United States $0.784B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.778B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Immunome (IMNM) United States $0.763B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
UniQure (QURE) Netherlands $0.759B 0.00
Pharming Group (PHAR) Netherlands $0.749B 0.00
Replimune (REPL) United States $0.719B 0.00
Vir Biotechnology (VIR) United States $0.715B 0.00
Sionna Therapeutics (SION) United States $0.699B 0.00
Gyre Therapeutics (GYRE) United States $0.696B 185.50
Phathom Pharmaceuticals (PHAT) United States $0.680B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.663B 0.00
AnaptysBio (ANAB) United States $0.660B 0.00
Immatics (IMTX) Germany $0.660B 0.00
Trevi Therapeutics (TRVI) United States $0.659B 0.00
Nuvation Bio (NUVB) United States $0.657B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.656B 0.00
GH Research (GHRS) Ireland $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.635B 14.72
Sana Biotechnology (SANA) United States $0.634B 0.00
Urogen Pharma (URGN) United States $0.622B 0.00
Cidara Therapeutics (CDTX) United States $0.620B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.615B 0.00
Arbutus Biopharma (ABUS) United States $0.599B 0.00
Upstream Bio (UPB) United States $0.588B 0.00
Castle Biosciences (CSTL) United States $0.588B 39.90
Sage Therapeutics (SAGE) United States $0.573B 0.00
Dianthus Therapeutics (DNTH) United States $0.567B 0.00
Iovance Biotherapeutics (IOVA) United States $0.564B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.554B 0.00
Arvinas (ARVN) United States $0.550B 0.00
Keros Therapeutics (KROS) United States $0.548B 0.00
Tango Therapeutics (TNGX) United States $0.543B 0.00
Maze Therapeutics (MAZE) United States $0.531B 0.00
MeiraGTx Holdings (MGTX) United States $0.531B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.501B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.495B 0.00
Kura Oncology (KURA) United States $0.491B 0.00
Myriad Genetics (MYGN) United States $0.484B 0.00
Tyra Biosciences (TYRA) United States $0.483B 0.00
Bicara Therapeutics (BCAX) United States $0.475B 0.00
Celcuity (CELC) United States $0.475B 0.00
Abivax SA (ABVX) France $0.470B 0.00
Septerna (SEPN) United States $0.468B 0.00
Cullinan Therapeutics (CGEM) United States $0.458B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.453B 0.00
Fortrea Holdings (FTRE) United States $0.451B 12.45
Cytek Biosciences (CTKB) United States $0.450B 0.00
ATyr Pharma (ATYR) United States $0.448B 0.00
Kamada (KMDA) Israel $0.443B 26.59
Mereo BioPharma Group - (MREO) United Kingdom $0.423B 0.00
REGENXBIO (RGNX) United States $0.421B 0.00
Precigen (PGEN) United States $0.419B 0.00
Rapport Therapeutics (RAPP) United States $0.417B 0.00
PureTech Health (PRTC) United States $0.412B 0.00
Zenas BioPharma (ZBIO) United States $0.401B 0.00
Fulcrum Therapeutics (FULC) United States $0.383B 0.00
ITeos Therapeutics (ITOS) United States $0.381B 0.00
Eton Pharmaceuticals (ETON) United States $0.376B 0.00
Rezolute (RZLT) United States $0.372B 0.00
Erasca (ERAS) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.371B 0.00
Tectonic Therapeutic (TECX) United States $0.370B 0.00
Solid Biosciences (SLDB) United States $0.366B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.362B 0.00
MBX Biosciences (MBX) United States $0.359B 0.00
Compass Therapeutics (CMPX) United States $0.354B 0.00
Northwest Biotherapeutics (NWBO) United States $0.349B 0.00
Emergent Biosolutions (EBS) United States $0.345B 0.00
Terns Pharmaceuticals (TERN) United States $0.335B 0.00
Absci (ABSI) United States $0.334B 0.00
XOMA Royalty (XOMA) United States $0.329B 0.00
Humacyte (HUMA) United States $0.329B 0.00
Prothena (PRTA) Ireland $0.327B 0.00
Amarin (AMRN) Ireland $0.325B 0.00
Citius Oncology (CTOR) United States $0.322B 0.00
Prime Medicine (PRME) United States $0.318B 0.00
Olema Pharmaceuticals (OLMA) United States $0.316B 0.00
Aura Biosciences (AURA) United States $0.316B 0.00
Astria Therapeutics (ATXS) United States $0.314B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.312B 0.00
Lifecore Biomedical (LFCR) United States $0.303B 0.00
Benitec Biopharma (BNTC) United States $0.298B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.297B 0.00
Atea Pharmaceuticals (AVIR) United States $0.295B 0.00
Abeona Therapeutics (ABEO) United States $0.294B 0.00
Inventiva S.A (IVA) France $0.292B 0.00
Aardvark Therapeutics (AARD) United States $0.291B 0.00
Ocugen (OCGN) United States $0.287B 0.00
Gossamer Bio (GOSS) United States $0.284B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.283B 57.50
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
Cartesian Therapeutics (RNAC) United States $0.277B 0.00
Alpha Teknova (TKNO) United States $0.273B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.270B 0.00
Foghorn Therapeutics (FHTX) United States $0.270B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.269B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.265B 0.00
Annexon (ANNX) United States $0.264B 0.00
Entrada Therapeutics (TRDA) United States $0.262B 8.53
Allogene Therapeutics (ALLO) United States $0.258B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Candel Therapeutics (CADL) United States $0.246B 0.00
Third Harmonic Bio (THRD) United States $0.245B 0.00
Palvella Therapeutics (PVLA) United States $0.244B 0.00
DBV Technologies S.A (DBVT) France $0.243B 0.00
Sagimet Biosciences (SGMT) United States $0.241B 0.00
Prima BioMed (IMMP) Australia $0.240B 0.00
MaxCyte (MXCT) United States $0.234B 0.00
Neurogene (NGNE) United States $0.230B 0.00
Tvardi Therapeutics (TVRD) United States $0.230B 0.00
Verastem (VSTM) United States $0.228B 0.00
Semper Paratus Acquisition (TVGN) United States $0.228B 0.00
Adherex Technologies (FENC) United States $0.228B 0.00
BioStem Technologies (BSEM) $0.226B 9.18
ProQR Therapeutics (PRQR) Netherlands $0.215B 0.00
Adocia (ADOCY) France $0.213B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.213B 0.00
I-Mab (IMAB) United States $0.210B 0.00
Cardiff Oncology (CRDF) United States $0.210B 0.00
Inhibrx Biosciences (INBX) United States $0.209B 0.12
Monopar Therapeutics (MNPR) United States $0.205B 0.00
ScPharmaceuticals (SCPH) United States $0.204B 0.00
Design Therapeutics (DSGN) United States $0.203B 0.00
AC Immune (ACIU) Switzerland $0.202B 0.00
Codexis (CDXS) United States $0.198B 0.00
Kodiak Sciences (KOD) United States $0.195B 0.00
SELLAS Life Sciences (SLS) United States $0.195B 0.00
CARGO Therapeutics (CRGX) United States $0.193B 0.00
Editas Medicine (EDIT) United States $0.191B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.191B 0.00
EnGene Holdings (ENGN) Canada $0.187B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.187B 0.00
CytomX Therapeutics (CTMX) United States $0.181B 4.69
GENFIT S.A (GNFT) France $0.180B 0.00
Innate Pharma S.A (IPHA) France $0.171B 0.00
Ventyx Biosciences (VTYX) United States $0.167B 0.00
Puma Biotechnology (PBYI) United States $0.165B 4.32
DiaMedica Therapeutics (DMAC) United States $0.165B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
Alumis (ALMS) United States $0.164B 0.00
Bright Minds Biosciences (DRUG) United States $0.164B 0.00
Voyager Therapeutics (VYGR) United States $0.164B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.161B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Anika Therapeutics (ANIK) United States $0.154B 0.00
Molecular Partners AG (MOLN) Switzerland $0.152B 0.00
Instil Bio (TIL) United States $0.151B 0.00
BioAge Labs (BIOA) United States $0.151B 0.00
Compugen (CGEN) Israel $0.148B 0.00
Alector (ALEC) United States $0.148B 0.00
Alpha Cognition (ACOG) Canada $0.146B 0.00
Kyverna Therapeutics (KYTX) United States $0.142B 0.00
Rapt Therapeutics (RAPT) United States $0.139B 0.00
Black Diamond Therapeutics (BDTX) United States $0.134B 39.17
Vor Biopharma (VOR) $0.132B 0.00
Agenus (AGEN) United States $0.131B 0.00
Skye Bioscience (SKYE) United States $0.127B 0.00
Immuneering (IMRX) United States $0.127B 0.00
Elicio Therapeutics (ELTX) United States $0.126B 0.00
Sangamo Therapeutics (SGMO) United States $0.126B 0.00
Seer (SEER) United States $0.125B 0.00
INmune Bio (INMB) United States $0.123B 0.00
Neumora Therapeutics (NMRA) United States $0.122B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.120B 0.00
23andMe Holding (MEHCQ) United States $0.120B 0.00
Fate Therapeutics (FATE) United States $0.119B 0.00
Nkarta (NKTX) United States $0.118B 0.00
Caribou Biosciences (CRBU) United States $0.117B 0.00
Actuate Therapeutics (ACTU) United States $0.117B 0.00
Genelux (GNLX) United States $0.113B 0.00
BioHarvest Sciences (BHST) Canada $0.110B 0.00
Theratechnologies (THTX) Canada $0.108B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.107B 0.00
Contineum Therapeutics (CTNM) United States $0.106B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.104B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
C4 Therapeutics (CCCC) United States $0.099B 0.00
Tenaya Therapeutics (TNYA) United States $0.099B 0.00
HilleVax (HLVX) United States $0.099B 0.00
BeyondSpring (BYSI) United States $0.099B 0.00
Coya Therapeutics (COYA) United States $0.098B 0.00
TuHURA Biosciences (HURA) United States $0.097B 0.00
IO Biotech (IOBT) Denmark $0.095B 0.00
Whitehawk Therapeutics (WHWK) United States $0.091B 0.00
Adagene (ADAG) China $0.090B 0.00
Entera Bio (ENTX) Israel $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.088B 0.00
Invivyd (IVVD) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.087B 0.00
Elutia (ELUT) United States $0.086B 0.00
Coherus Oncology (CHRS) United States $0.086B 0.00
XBiotech (XBIT) United States $0.085B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.085B 0.00
OKYO Pharma (OKYO) $0.083B 0.00
Jasper Therapeutics (JSPR) United States $0.082B 0.00
Forte Biosciences (FBRX) United States $0.081B 0.00
Cellectis S.A (CLLS) France $0.081B 0.00
Climb Bio (CLYM) United States $0.080B 0.00
Cabaletta Bio (CABA) United States $0.080B 0.00
Seres Therapeutics (MCRB) United States $0.079B 0.00
TScan Therapeutics (TCRX) United States $0.079B 0.00
TELA Bio (TELA) United States $0.078B 0.00
Inovio Pharmaceuticals (INO) United States $0.077B 0.00
Pliant Therapeutics (PLRX) United States $0.077B 0.00
Zura Bio (ZURA) United States $0.072B 0.00
Oncolytics Biotech (ONCY) Canada $0.071B 0.00
Quince Therapeutics (QNCX) United States $0.070B 0.00
Biomea Fusion (BMEA) United States $0.068B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.068B 0.00
Immunic (IMUX) United States $0.067B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.065B 0.00
IGM Biosciences (IGMS) United States $0.065B 0.00
PDS Biotechnology (PDSB) United States $0.064B 0.00
Quantum Biopharma (QNTM) Canada $0.063B 0.00
Alto Neuroscience (ANRO) United States $0.063B 0.00
Sutro Biopharma (STRO) United States $0.062B 0.00
Akoya Biosciences (AKYA) United States $0.062B 0.00
Immix Biopharma (IMMX) United States $0.060B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.060B 0.00
Clearside Biomedical (CLSD) United States $0.060B 0.00
Repare Therapeutics (RPTX) Canada $0.060B 0.00
Opus Genetics (IRD) United States $0.058B 0.00
VistaGen Therapeutics (VTGN) United States $0.057B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
ZIVO Bioscience (ZIVO) United States $0.057B 0.00
Genenta Science S.p.A (GNTA) Italy $0.057B 0.00
Senti Biosciences (SNTI) United States $0.056B 0.00
Earth Science Tech (ETST) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.056B 0.00
Connect Biopharma Holdings (CNTB) United States $0.056B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
Fortress Biotech (FBIO) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
CervoMed (CRVO) United States $0.053B 0.00
Adicet Bio (ACET) United States $0.052B 0.00
Renovaro (RENB) United States $0.050B 0.00
Kalaris Therapeutics (KLRS) United States $0.049B 0.00
Adverum Biotechnologies (ADVM) United States $0.048B 0.00
Precision BioSciences (DTIL) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.047B 0.00
RenovoRx (RNXT) United States $0.047B 0.00
VTv Therapeutics (VTVT) United States $0.046B 0.00
Applied Therapeutics (APLT) United States $0.046B 0.00
Werewolf Therapeutics (HOWL) United States $0.046B 0.00
Celularity (CELU) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.044B 0.00
ABVC BioPharma (ABVC) United States $0.044B 0.00
Scilex Holding (SCLX) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Shattuck Labs (STTK) United States $0.041B 0.00
Annovis Bio (ANVS) United States $0.040B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
PepGen (PEPG) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.037B 0.00
Exicure (XCUR) United States $0.037B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Mersana Therapeutics (MRSN) United States $0.036B 0.00
Artiva Biotherapeutics (ARTV) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Alterity Therapeutics - (ATHE) Australia $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Clene (CLNN) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Rein Therapeutics (RNTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
Dyadic (DYAI) United States $0.030B 0.00
KALA BIO (KALA) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.028B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.027B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.024B 0.00
Curis (CRIS) United States $0.023B 0.00
Boundless Bio (BOLD) United States $0.023B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
ALX Oncology Holdings (ALXO) United States $0.022B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Elevation Oncology (ELEV) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
Passage Bio (PASG) United States $0.021B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
Generation Bio (GBIO) United States $0.020B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
CalciMedica (CALC) United States $0.020B 0.00
Longeveron (LGVN) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Q32 Bio (QTTB) United States $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Cingulate (CING) United States $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.016B 0.00
SAB Biotherapeutics (SABS) United States $0.016B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Hoth Therapeutics (HOTH) United States $0.015B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Synlogic (SYBX) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
UNITY Biotechnology (UBX) United States $0.013B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
MetaVia (MTVA) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Equillium (EQ) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Leap Therapeutics (LPTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
GT Biopharma (GTBP) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.008B 0.00
Synaptogenix (SNPX) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Apollomics (APLM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
IN8bio (INAB) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Moleculin Biotech (MBRX) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00